Kailera Therapeutics stake held by Canada Pension Plan

Canada Pension Plan Investment Board, through its wholly owned subsidiary CPP Investment Board Private Holdings (4) Inc., reports beneficial ownership of 7,304,688 shares of Kailera Therapeutics, Inc. common stock.

Rhea-AI Filing Summary

Canada Pension Plan Investment Board, through its wholly owned subsidiary CPP Investment Board Private Holdings (4) Inc., reports beneficial ownership of 7,304,688 shares of Kailera Therapeutics, Inc. common stock. This represents 5.6% of the company’s common stock based on 129,565,608 shares outstanding as of May 20, 2026.

The reporting entities have shared voting and dispositive power over all 7,304,688 shares and no sole voting or dispositive power. The shares are held directly by CPP Investment Board Private Holdings (4) Inc., with Canada Pension Plan Investment Board deemed to share beneficial ownership through its subsidiary.

Key Figures

Shares beneficially owned: 7,304,688 shares Percent of class: 5.6% Shares outstanding: 129,565,608 shares +2 more

5 metrics

Shares beneficially owned 7,304,688 shares Common stock of Kailera Therapeutics, Inc. beneficially owned by the reporting persons

Percent of class 5.6% Portion of Kailera Therapeutics common stock beneficially owned by the reporting persons

Shares outstanding 129,565,608 shares Kailera Therapeutics common stock outstanding as of May 20, 2026

Shared voting power 7,304,688 shares Shares over which the reporting persons share voting power

Sole voting power 0 shares Shares over which the reporting persons have sole voting power

Key Terms

Beneficially owned, Dispositive power, Percent of class, CUSIP Number

4 terms

Beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: See Item 9 on the cover pages."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Dispositive power financial

"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 7,304,688.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Percent of class financial

"(b) | Percent of class: See Item 11 on the cover pages."

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

CUSIP Number financial

"(e) | CUSIP Number(s): 482931102"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Kailera Therapeutics (KLRA) shares does Canada Pension Plan Investment Board beneficially own?

Canada Pension Plan Investment Board, through its subsidiary, beneficially owns 7,304,688 shares of Kailera Therapeutics common stock. These shares are directly held by CPP Investment Board Private Holdings (4) Inc. and reported as jointly owned by both entities.

What percentage of Kailera Therapeutics (KLRA) is owned by the reporting persons in this Schedule 13G?

The reporting persons disclose beneficial ownership of 5.6% of Kailera Therapeutics common stock. This percentage is calculated using 129,565,608 shares outstanding as of May 20, 2026, as stated in Kailera’s Form 10-Q.

Who are the reporting persons in the Kailera Therapeutics (KLRA) Schedule 13G filing?

The reporting persons are Canada Pension Plan Investment Board and its wholly owned subsidiary CPP Investment Board Private Holdings (4) Inc.. Both are organized under the laws of Canada and share beneficial ownership of the reported shares.

Do the reporting persons have sole or shared voting power over Kailera Therapeutics (KLRA) shares?

The reporting persons have 0 shares with sole voting power and 7,304,688 shares with shared voting power. They also have shared dispositive power over the same number of shares and no sole dispositive power.

How was the 5.6% ownership in Kailera Therapeutics (KLRA) calculated in the Schedule 13G?

The 5.6% figure is based on 7,304,688 shares beneficially owned out of 129,565,608 shares of Kailera common stock outstanding. The outstanding share count comes from Kailera’s Form 10-Q dated May 26, 2026.

Where are the reporting persons for the Kailera Therapeutics (KLRA) Schedule 13G based?

Both reporting persons have their principal business address at One Queen Street East, Suite 2500, Toronto, Ontario M5C 2W5, Canada. Each is organized under the laws of Canada at the federal level.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:04 PM EDT Accepted by SEC EDGAR 08/14/2026 - 04:01 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Kailera Therapeutics, Inc.

(Name of Issuer)

Common Stock, $0.00001 par value per share

(Title of Class of Securities)

482931102

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 482931102

1

Names of Reporting Persons

CPP Investment Board Private Holdings (4) Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,304,688.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,304,688.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,304,688.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: Item 11 is calculated based on a total of 129,565,608 shares of common stock of the issuer outstanding as of May 20, 2026, as disclosed in the issuer's Form 10-Q filed with the SEC on May 26, 2026. Shares reported on this Schedule 13G are held directly by CPP Investment Board Private Holdings (4) Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board.

SCHEDULE 13G

CUSIP Number(s): 482931102

1

Names of Reporting Persons

Canada Pension Plan Investment Board

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,304,688.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,304,688.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,304,688.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

FI

Comment for Type of Reporting Person: Item 11 is calculated based on a total of 129,565,608 shares of common stock of the issuer outstanding as of May 20, 2026, as disclosed in the issuer's Form 10-Q filed with the SEC on May 26, 2026. Shares reported on this Schedule 13G are held directly by CPP Investment Board Private Holdings (4) Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Kailera Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 180 Third Avenue, 4th Floor Waltham, MA 02451
Item 2.
(a)	Name of person filing: Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of: Canada Pension Plan Investment Board CPP Investment Board Private Holdings (4) Inc.
(b)	Address or principal business office or, if none, residence: The principal business address of each of the Reporting Persons is as follows: One Queen Street East Suite 2500 Toronto, Ontario M5C 2W5 Canada
(c)	Citizenship: Each of the Reporting Persons is organized under the laws of Canada.
(d)	Title of class of securities: Common Stock, $0.00001 par value per share
(e)	CUSIP Number(s): 482931102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Item 9 on the cover pages. The securities reported herein are directly held by CPP Investment Board Private Holdings (4) Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board. As such, the Reporting Persons may be deemed to have shared voting power and dispositive power with respect to such securities.
(b)	Percent of class: See Item 11 on the cover pages.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Item 5 on the cover pages.
	(ii) Shared power to vote or to direct the vote: See Item 6 on the cover pages.
	(iii) Sole power to dispose or to direct the disposition of: See Item 7 on the cover pages.
	(iv) Shared power to dispose or to direct the disposition of: See Item 8 on the cover pages.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CPP Investment Board Private Holdings (4) Inc.

Signature:	/s/ Pierre Abinakle
Name/Title:	Vice President
Date:	08/14/2026

Canada Pension Plan Investment Board

Signature:	/s/ Howard Rusak
Name/Title:	Managing Director, Legal
Date:	08/14/2026

Comments accompanying signature: See Exhibit 99.1 Power of Attorney of Canada Pension Plan Investment Board

Exhibit Information

99.1 Power of Attorney of Canada Pension Plan Investment Board 99.2 Joint Filing Agreement